
Sushil Mehta
About Sushil Mehta
Data last updated:
Sushil Mehta is a Director at Zenex Animal Health India Private Limited (since 2022), Director at Qunu Labs Private Limited (since 2019) and Director at Nextgen In-Vitro Diagnostics Private Limited (since 2016), and holds 1 more current directorship. The companies operate in Healthcare, Information Technology and Life Sciences. The 3 current companies with reported revenue have a combined latest revenue of ₹1,066 Cr; the largest is Zenex Animal Health India Private Limited at ₹1,023 Cr (FY 2025). Earlier, Sushil Mehta was a Director at Avantor Performance Materials India Private Limited (2005–2022) and Director at Tropical Animal Genetics Private Limited (2018–2021) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Sep 2022 | 2021 | ₹1,023 Cr (FY 2025) | Active | |
| Director | 05 Apr 2019 | 2016 | ₹40.53 Cr (FY 2025) | Active | |
| Director | 12 Oct 2016 | 2015 | ₹1.87 Cr (FY 2024) | Active | |
| Director | 05 Mar 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Dec 2005 | 1991 | ₹887 Cr (FY 2023) | Active | |
| Director | 30 Jul 2018 | 2014 | ₹15.55 Cr (FY 2025) | Active | |
| Director | 10 Oct 2008 | 2007 | ₹402 Cr (FY 2025) | Active | |
| Director | 04 Feb 2008 | 1991 | Amalgamated | ||
| Director | 01 Dec 2012 | 2009 | Strike Off | ||
| Director | 27 Jan 2020 | 2016 | Strike Off | ||
| Director | 14 Dec 2023 | 1992 | ₹108 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sushil Mehta
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushil Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushil Mehta
Sushil Mehta currently holds 4 directorships: Zenex Animal Health India Private Limited (Director, since 02 Sep 2022, revenue ₹1,023 Cr (FY 2025)); Qunu Labs Private Limited (Director, since 05 Apr 2019, revenue ₹40.53 Cr (FY 2025)); Nextgen In-Vitro Diagnostics Private Limited (Director, since 12 Oct 2016, revenue ₹1.87 Cr (FY 2024)); Palm Spring Welfare Foundation (Director, since 05 Mar 2024).
Sushil Mehta was first appointed on 06 Dec 2005 as Director at Avantor Performance Materials India Private Limited. The most recent appointment on record is 05 Mar 2024 at Palm Spring Welfare Foundation.
The 3 current companies of Sushil Mehta that report revenue have a combined latest revenue of ₹1,066 Cr: Zenex Animal Health India Private Limited ₹1,023 Cr (FY 2025); Qunu Labs Private Limited ₹40.53 Cr (FY 2025); Nextgen In-Vitro Diagnostics Private Limited ₹1.87 Cr (FY 2024).
Sushil Mehta held 7 earlier board appointments: Avantor Performance Materials India Private Limited (Director, 06 Dec 2005 to 20 Jun 2022); Tropical Animal Genetics Private Limited (Director, 30 Jul 2018 to 01 Sep 2021); Zoetis India Limited (Director, 10 Oct 2008 to 01 Dec 2009); Alved Pharma Foods Private Limited (Director, from 04 Feb 2008); J.T. Baker Chemicals Private Limited (Director, from 01 Dec 2012); and 2 more.
The current boards of Sushil Mehta's companies include Andrew Rowan Ian Yee (Zenex Animal Health India Private Limited), Arun Atrey (Zenex Animal Health India Private Limited), Manish Gaur (Zenex Animal Health India Private Limited), Renuka Ramnath (Zenex Animal Health India Private Limited), Swati (Zenex Animal Health India Private Limited), Utpal Hemendra Sheth (Zenex Animal Health India Private Limited), among others.